The number of neurological diseases worldwide continues to rise, writes Diena.
Modern treatment is not accessible
According to forecasts, by 2030, 13% of all diseases will be classified as neurological, highlighting the need for timely recognition and treatment. Unfortunately, diagnoses are often made too late - this is particularly true for migraine, dementia, and Parkinson's disease.
One of the most serious neurological diseases is dementia, which has recently been increasingly diagnosed in younger age groups. The progression of the disease poses serious risks to patient safety, especially if they live alone. At the same time, long-term social care and rehabilitation centers (LSU) lack resources: the waiting time for services often reaches one year, and the number of dementia patients in such institutions has increased by about 10%.
This was stated by Sanita Janka, the director of the health department, during a presentation by the Ministry of Health, noting that effective pathogenetic therapy for dementia is currently only available through the use of acetylcholinesterase inhibitors.
As for migraine, its adequate treatment is often hindered by the widespread stereotype that it is just a common headache. It should be noted that migraine is a heterogeneous disease: treatment that is suitable for one patient may be ineffective for another. Despite the widespread prevalence of migraine and its significant impact on workforce productivity, funding for research in this area has historically been insufficient, the Ministry of Health points out.
Funding in the fields of algology and neurology is also inadequate. In algology, both the volume of outpatient visits and allocated funds have increased over the past two years, while in neurology, funding in 2025 is projected to be lower than in 2023. It is necessary to investigate the reasons for the reduction and seek solutions to increase funding, emphasizes the Ministry of Health.
